145 related articles for article (PubMed ID: 31506287)
1. Inherited predisposition to myeloid malignancies.
Godley LA
Blood Adv; 2019 Sep; 3(17):2688. PubMed ID: 31506287
[No Abstract] [Full Text] [Related]
2. Germ line predisposition to myeloid malignancies appearing in adulthood.
Crysandt M; Brings K; Beier F; Thiede C; Brümmendorf TH; Jost E
Expert Rev Hematol; 2018 Aug; 11(8):625-636. PubMed ID: 29958021
[TBL] [Abstract][Full Text] [Related]
3. A new family with a germline ANKRD26 mutation and predisposition to myeloid malignancies.
Marquez R; Hantel A; Lorenz R; Neistadt B; Wong J; Churpek JE; Mardini NA; Shaukat I; Gurbuxani S; Miller JL; Godley LA
Leuk Lymphoma; 2014 Dec; 55(12):2945-6. PubMed ID: 24628296
[No Abstract] [Full Text] [Related]
4. Cancer predisposition syndromes associated with myeloid malignancy.
Quinn E; Nichols KE
Semin Hematol; 2017 Apr; 54(2):115-122. PubMed ID: 28637615
[TBL] [Abstract][Full Text] [Related]
5. Myeloid neoplasms with germline predisposition: Practical considerations and complications in the search for new susceptibility loci.
Carraway HE; LaFramboise T
Best Pract Res Clin Haematol; 2020 Sep; 33(3):101191. PubMed ID: 33038980
[TBL] [Abstract][Full Text] [Related]
6. The germline sequence variant rs2736100_C in TERT associates with myeloproliferative neoplasms.
Oddsson A; Kristinsson SY; Helgason H; Gudbjartsson DF; Masson G; Sigurdsson A; Jonasdottir A; Jonasdottir A; Steingrimsdottir H; Vidarsson B; Reykdal S; Eyjolfsson GI; Olafsson I; Onundarson PT; Runarsson G; Sigurdardottir O; Kong A; Rafnar T; Sulem P; Thorsteinsdottir U; Stefansson K
Leukemia; 2014 Jun; 28(6):1371-4. PubMed ID: 24476768
[No Abstract] [Full Text] [Related]
7. Rare germline variant contributions to myeloid malignancy susceptibility.
Li ST; Wang J; Wei R; Shi R; Adema V; Nagata Y; Kerr CM; Kuzmanovic T; Przychodzen B; Sole F; Maciejewski JP; LaFramboise T
Leukemia; 2020 Jun; 34(6):1675-1678. PubMed ID: 31911633
[No Abstract] [Full Text] [Related]
8. [Myeloid neoplasms with germline predisposition].
Yoshida K
Rinsho Ketsueki; 2023; 64(9):949-954. PubMed ID: 37793870
[TBL] [Abstract][Full Text] [Related]
9. Myeloid Neoplasms with Germline Predisposition.
Geyer JT
Pathobiology; 2019; 86(1):53-61. PubMed ID: 30048985
[TBL] [Abstract][Full Text] [Related]
10. Myeloid Malignancies: Recognizing the Risk of Germline Predisposition and Supporting Patients and Families.
Friend P; Mahon SM
Clin J Oncol Nurs; 2021 Oct; 25(5):519-522. PubMed ID: 34533515
[TBL] [Abstract][Full Text] [Related]
11. An analysis of the
Palmer D; Nacheva E
Leuk Lymphoma; 2021 May; 62(5):1255-1258. PubMed ID: 33349109
[No Abstract] [Full Text] [Related]
12. Advances in understanding the pathogenesis of familial myeloproliferative neoplasms.
Rumi E; Cazzola M
Br J Haematol; 2017 Sep; 178(5):689-698. PubMed ID: 28444727
[TBL] [Abstract][Full Text] [Related]
13. JAK-mutant myeloproliferative neoplasms.
Levine RL
Curr Top Microbiol Immunol; 2012; 355():119-33. PubMed ID: 21823028
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive molecular characterization of myeloid malignancies with 9q deletion.
Hartmann L; Haferlach T; Meggendorfer M; Kern W; Haferlach C; Stengel A
Leuk Lymphoma; 2019 Oct; 60(10):2591-2593. PubMed ID: 30844315
[No Abstract] [Full Text] [Related]
15. [Research progress on molecular pathogenesis of myeloproliferative neoplasms].
Liu L; Xiao ZJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Feb; 19(1):239-43. PubMed ID: 21362261
[TBL] [Abstract][Full Text] [Related]
16. A novel RUNX1 mutation in familial platelet disorder with propensity to develop myeloid malignancies.
Kirito K; Sakoe K; Shinoda D; Takiyama Y; Kaushansky K; Komatsu N
Haematologica; 2008 Jan; 93(1):155-6. PubMed ID: 18166807
[TBL] [Abstract][Full Text] [Related]
17. Myeloid malignancies with somatic
Alfayez M; Wang SA; Bannon SA; Kontoyiannis DP; Kornblau SM; Orange JS; Mace EM; DiNardo CD
Leuk Lymphoma; 2019 Aug; 60(8):2025-2033. PubMed ID: 30648453
[TBL] [Abstract][Full Text] [Related]
18. Recognition of familial myeloid neoplasia in adults.
Brown AL; Churpek JE; Malcovati L; Döhner H; Godley LA
Semin Hematol; 2017 Apr; 54(2):60-68. PubMed ID: 28637618
[TBL] [Abstract][Full Text] [Related]
19. GATA2 and secondary mutations in familial myelodysplastic syndromes and pediatric myeloid malignancies.
Wang X; Muramatsu H; Okuno Y; Sakaguchi H; Yoshida K; Kawashima N; Xu Y; Shiraishi Y; Chiba K; Tanaka H; Saito S; Nakazawa Y; Masunari T; Hirose T; Elmahdi S; Narita A; Doisaki S; Ismael O; Makishima H; Hama A; Miyano S; Takahashi Y; Ogawa S; Kojima S
Haematologica; 2015 Oct; 100(10):e398-401. PubMed ID: 26022708
[No Abstract] [Full Text] [Related]
20. Association of JAK2-V617F Mutations Detected by Solid Tumor Sequencing With Coexistent Myeloproliferative Neoplasms.
Riedlinger G; Hadigol M; Khiabanian H; Ganesan S
JAMA Oncol; 2019 Feb; 5(2):265-267. PubMed ID: 30605212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]